INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2008

A review argues against universal statin use for all diabetic patients and indiscriminate polypill use for cardiovascular prevention.

This article discusses primary and secondary cardiovascular prevention in people with diabetes, addressing suboptimal target implementation and noncompliance. It reviews proposed simplified strategies, including universal aspirin and statin treatment, the 'polypill,' and the standardized nutrient concept of a 'polymeal.' The authors present a viewpoint arguing against prescribing statins to every patient with diabetes and specifically against the indiscriminate use of a polypill.

Study type
Narrative review / perspective
Who was studied
People with diabetes and the general population
What was measured
Cardiovascular prevention strategies, polypill, polymeal, and statin/aspirin use

THE PAPER

Should we be more aggressive in the therapy against cardiovascular risk factors? Should we prescribe statin and aspirin for every diabetic patient, or is it time for a polypill?

Stirban AO, Tschoepe D. Diabetes Care, 2008.

PubMed 18227490 ↗DOI 10.2337/dc08-s254 ↗

Heart & arteriesDiabetes & blood sugar

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.